Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Gewählte Publikation:

SHR Neuro Krebs Kardio Lipid

Pascal, L; Tucunduva, L; Ruggeri, A; Blaise, D; Ceballos, P; Chevallier, P; Cornelissen, J; Maillard, N; Tabrizi, R; Petersen, E; Linkesch, W; Sengeloev, H; Kenzey, C; Pagliuca, A; Holler, E; Einsele, H; Gluckman, E; Rocha, V; Yakoub-Agha, I; Eurocord and the European Society for Blood and Marrow Transplantation.
Impact of ATG-containing reduced-intensity conditioning after single- or double-unit allogeneic cord blood transplantation.
Blood. 2015; 126(8):1027-1032 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG


Autor/innen der Med Uni Graz:
Lechner Evelyne
Linkesch Werner

Dimensions Citations:

Plum Analytics:
We analyzed 661 adult patients who underwent single-unit (n = 226) or double-unit (n = 435) unrelated cord blood transplantation (UCBT) following a reduced-intensity conditioning (RIC) consisting of low-dose total body irradiation (TBI), cyclophosphamide, and fludarabine (Cy/Flu/TBI200). Eighty-two patients received rabbit antithymocyte globulin (ATG) as part of the conditioning regimen (ATG group), whereas 579 did not (non-ATG group). Median age at UCBT was 54 years, and diagnoses were acute leukemias (51%), myelodysplastic syndrome/myeloproliferative neoplasm (19%), and lymphoproliferative diseases (30%). Forty-four percent of patients were transplanted with advanced disease. All patients received ≥4 antigens HLA-matched UCBT. Median number of collected total nucleated cells was 4.4 × 10(7)/kg. In the ATG group, on 64 evaluable patients, ATG was discontinued 1 (n = 27), 2 (n = 20), or > 2 days before the graft infusion (n = 17). In multivariate analyses, the use of ATG was associated with decreased incidence of acute graft-versus-host disease (hazard ratio [HR], 0.31; 95% confidence interval [CI], 0.17-0.55; P < .0001), higher incidence of nonrelapse mortality (HR, 1.68; 95% CI, 1.16-2.43; P = .0009), and decreased overall survival (HR, 1.69; 95% CI, 1.19-2.415; P = .003). Collectively, our results suggest that the use of ATG could be detrimental, especially if given too close to graft infusion in adults undergoing UCBT following Cy/Flu/TBI200 regimen. © 2015 by The American Society of Hematology.
Find related publications in this database (using NLM MeSH Indexing)
Adolescent -
Adult -
Aged -
Allografts -
Antilymphocyte Serum - therapeutic use
Cord Blood Stem Cell Transplantation - methods
Cyclophosphamide - administration & dosage
Female -
Graft vs Host Disease - epidemiology
Humans -
Kaplan-Meier Estimate -
Lymphoproliferative Disorders - drug therapy
Male -
Middle Aged -
Myelodysplastic Syndromes - drug therapy
Proportional Hazards Models -
Transplantation Conditioning - methods
Vidarabine - administration & dosage
Vidarabine - analogs & derivatives
Whole-Body Irradiation -
Young Adult -

© Meduni Graz Impressum